Ardena Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Private

  • Employees
  • 165

Employees

  • Latest Deal Type
  • Debt - Acquisition

  • Financing Rounds
  • 4

  • Investments
  • 5

Ardena General Information

Description

Provider of early-stage drug development and manufacturing services for small-to-mid-sized biopharma companies. The company operates as a contract partner, delivering pre-clinical and clinical drug development, drug research, manufacturing and bioanalysis services, thereby guiding companies through the drug discovery process to help create effective and compliant pharmaceutical products for clinical trials.

Contact Information

Website
www.ardena.com
Formerly Known As
PharmaVize
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Kleimoer 4
  • 9030 Mariakerke
  • Belgium
+32 09
Primary Industry
BPO/Outsource Services
Other Industries
Drug Discovery
Pharmaceuticals
Biotechnology
Vertical(s)
Manufacturing
Corporate Office
  • Kleimoer 4
  • 9030 Mariakerke
  • Belgium
+32 09

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ardena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ardena‘s full profile, request access.

Request a free trial

Ardena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of early-stage drug development and manufacturing services for small-to-mid-sized biopharma companies. The comp
BPO/Outsource Services
Mariakerke, Belgium
165 As of 2026

Seraing, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ardena Competitors (1)

One of Ardena’s competitors is Kaneka Eurogentec, a Formerly PE-Backed company based in Seraing, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kaneka Eurogentec Formerly PE-Backed Seraing, Belgium
You’re viewing 1 of 1 competitors. Get the full list »

Ardena Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

Ardena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10988479-B1 Morphic forms of trilaciclib and methods of manufacture thereof Active 15-Jun-2020
US-12168666-B2 Morphic forms of trilaciclib and methods of manufacture thereof Active 15-Jun-2020
US-20210387993-A1 Morphic forms of trilaciclib and methods of manufacture thereof Active 15-Jun-2020 C07D487/20

Ardena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ardena Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ardena‘s full profile, request access.

Request a free trial

Ardena Investments (5)

Ardena’s most recent deal was a Buyout/LBO with Catalent (Oral Solids Development and Small-Scale Manufacturing Facility in Somerset, New Jersey). The deal was made on 04-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Catalent (Oral Solids Development and Small-Scale Manufacturing Facility in Somerset, New Jersey) 04-Feb-2025 Buyout/LBO Buildings and Property
Idifarma Desarrollo Farmacéutico 01-Sep-2021 Buyout/LBO Other Pharmaceuticals and Biotechnology
Syntagon 08-May-2018 Buyout/LBO Pharmaceuticals
ChemConnection 14-Mar-2018 Buyout/LBO Other Pharmaceuticals and Biotechnology
Analytical Biochemical Laboratory 21-Sep-2017 Buyout/LBO Laboratory Services (Healthcare)
To view Ardena’s complete investments history, request access »

Ardena Exits (1)

Ardena’s most recent exit was on 08-May-2018 from Syntagon. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Syntagon 08-May-2018 Completed
  • 2 buyers
To view Ardena’s complete exits history, request access »

Ardena Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Analytical Biochemical Laboratory Assen, Netherlands 1969

Ardena FAQs

  • When was Ardena founded?

    Ardena was founded in 1994.

  • Where is Ardena headquartered?

    Ardena is headquartered in Mariakerke, Belgium.

  • What is the size of Ardena?

    Ardena has 165 total employees.

  • What industry is Ardena in?

    Ardena’s primary industry is BPO/Outsource Services.

  • Is Ardena a private or public company?

    Ardena is a Private company.

  • What is Ardena’s current revenue?

    The current revenue for Ardena is .

  • Who are Ardena’s investors?

    GHO Capital has invested in Ardena.

  • Who are Ardena’s competitors?

    Kaneka Eurogentec is a competitor of Ardena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process